SRNE - Sorrento Therapeutics rises on order for COVISTIX COVID tests in Brazil
Shares of Sorrento Therapeutics (SRNE +6.0%) are modestly higher in afternoon trading after the company announced an order from a large diagnostic laboratory in Brazil for its COVISTIX COVID-19 test. The company said the tests will begin to be delivered by the end of the year. Sorrento says that COVISTIX can provide results with a shallow nasal swab in 15-20 minutes. Find out why Seeking Alpha contributor SimOne Trading believes that COVISTIX will help support growth in Sorrento's stock price.
For further details see:
Sorrento Therapeutics rises on order for COVISTIX COVID tests in Brazil